SCHEMBL11923230

SCHEMBL11923230

CC(C)N(C(=O)c1cnc(N2CCCCC2)nc1-c1ccccc1F)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PTPN11 Q06124 3/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ TACR1 P25103 1/20 0.40
▸ HTR2C P28335 2/20 0.38
▸ AKT1 P31749 1/20 0.38
▸ AKT2 P31751 1/20 0.38
▸ AKT3 Q9Y243 1/20 0.38
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ GBA1 P04062 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ HIF1A Q16665 1/20 0.35
▸ STK17A Q9UEE5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11923265 0.92 TACR1 (0.41) PTPN11SMN1; SMN2POLBTACR1HTR2C
SCHEMBL11923211 0.92 TACR1 (0.39) PTPN11SMN1; SMN2POLBTACR1HTR2C
SCHEMBL11923180 0.91 TACR1 (0.49) PTPN11SMN1; SMN2TACR1HTR2CMAPT
SCHEMBL8267649 0.91 MAPT (0.40) PTPN11SMN1; SMN2POLBTACR1LMNA
SCHEMBL11923223 0.91 PTPN11 (0.43) PTPN11TACR1LMNAMAPTNPSR1
SCHEMBL11923296 0.91 PTPN11 (0.43) PTPN11SMN1; SMN2TACR1HTR2CMAPT
SCHEMBL11923188 0.90 TACR1 (0.41) PTPN11SMN1; SMN2POLBTACR1HTR2C
SCHEMBL11923253 0.90 MAPT (0.40) SMN1; SMN2POLBTACR1HTR2CLMNA
SCHEMBL11923249 0.89 TACR1 (0.38) SMN1; SMN2POLBTACR1HTR2CAKT1
SCHEMBL8267708 0.89 GPBAR1 (0.43) PTPN11SMN1; SMN2POLBTACR1AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546414-B2 Ion channel modulators and methods of use VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-10-01 — — US disclosed
US-8546414-B2 Ion channel modulators and methods of use VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-10-01 — — US disclosed
US-20120270318-A1 ION CHANNEL MODULATORS AND METHODS OF USE VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-10-25 — — US disclosed
US-20120270318-A1 ION CHANNEL MODULATORS AND METHODS OF USE VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-10-25 — — US disclosed
US-8236815-B2 Ion channel modulators and methods of uses VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-08-07 — — US disclosed
US-8236815-B2 Ion channel modulators and methods of uses VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-08-07 — — US disclosed
US-7767680-B2 Ion channel modulators and methods of use VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-08-03 — — US disclosed
US-7767680-B2 Ion channel modulators and methods of use VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-08-03 — — US disclosed
Send feedback